Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The revision indicator updated from v3.5.3 to v3.5.4, signaling a new page release. This reflects an internal update to the page rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-05-15T15:35:00.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3 in the site footer, reflecting a minor ClinicalTrials.gov software/content-display update rather than any change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:35:53.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2. No visible changes to the study record content are indicated.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:36.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    B-cell chronic lymphocytic leukemia was added to the list of conditions described on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:51.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision labels updated from v3.4.3 to v3.5.0. No visible changes to study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:54.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:47.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.